Literature DB >> 31454292

Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.

Denise Wootten1,2, Laurence J Miller1,3.   

Abstract

Recent advances in our understanding of the structure and function of class B G protein-coupled receptors (GPCRs) provide multiple opportunities for targeted development of allosteric modulators. Given the pleiotropic signaling patterns emanating from these receptors in response to a variety of natural agonist ligands, modulators have the potential to sculpt the responses to meet distinct needs of different groups of patients. In this review, we provide insights into how this family of GPCRs differs from the rest of the superfamily, how orthosteric agonists bind and activate these receptors, the potential for allosteric modulators to interact with various regions of these targets, and the allosteric influence of endogenous proteins on the pharmacology of these receptors, all of which are important considerations when developing new therapies.

Entities:  

Keywords:  GPCRs; RAMPs; allosteric modulation; biased agonism; structure function

Mesh:

Substances:

Year:  2019        PMID: 31454292      PMCID: PMC7092389          DOI: 10.1146/annurev-pharmtox-010919-023301

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  97 in total

Review 1.  Biased signalling and allosteric machines: new vistas and challenges for drug discovery.

Authors:  Terry P Kenakin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  New beta-alanine derivatives are orally available glucagon receptor antagonists.

Authors:  Jesper Lau; Carsten Behrens; Ulla G Sidelmann; Lotte B Knudsen; Behrend Lundt; Christian Sams; Lars Ynddal; Christian L Brand; Lone Pridal; Anthony Ling; Dan Kiel; Michael Plewe; Shengua Shi; Peter Madsen
Journal:  J Med Chem       Date:  2007-01-11       Impact factor: 7.446

Review 3.  Structure and Function of Small Non-Peptide CRF Antagonists and their Potential Clinical Use.

Authors:  Hesham Fahmy; Bhimanna Kuppast; Mohamed Teleb Ismail
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

4.  Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations.

Authors:  Denise Wootten; John Simms; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

5.  Differential engagement of polar networks in the glucagon-like peptide 1 receptor by endogenous variants of the glucagon-like peptide 1.

Authors:  S G B Furness; A Christopoulos; P M Sexton; D Wootten
Journal:  Biochem Pharmacol       Date:  2018-08-25       Impact factor: 5.858

6.  Cholesterol increases kinetic, energetic, and mechanical stability of the human β2-adrenergic receptor.

Authors:  Michael Zocher; Cheng Zhang; Søren G F Rasmussen; Brian K Kobilka; Daniel J Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

Review 7.  The expanding repertoire of receptor activity modifying protein (RAMP) function.

Authors:  Klara R Klein; Brooke C Matson; Kathleen M Caron
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-01-06       Impact factor: 8.250

8.  Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor.

Authors:  Carlos J Baier; Jacques Fantini; Francisco J Barrantes
Journal:  Sci Rep       Date:  2011-08-19       Impact factor: 4.379

9.  Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.

Authors:  Jason M Booe; Christopher S Walker; James Barwell; Gabriel Kuteyi; John Simms; Muhammad A Jamaluddin; Margaret L Warner; Roslyn M Bill; Paul W Harris; Margaret A Brimble; David R Poyner; Debbie L Hay; Augen A Pioszak
Journal:  Mol Cell       Date:  2015-05-14       Impact factor: 17.970

10.  Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor.

Authors:  Yi-Lynn Liang; Maryam Khoshouei; Giuseppe Deganutti; Alisa Glukhova; Cassandra Koole; Thomas S Peat; Mazdak Radjainia; Jürgen M Plitzko; Wolfgang Baumeister; Laurence J Miller; Deborah L Hay; Arthur Christopoulos; Christopher A Reynolds; Denise Wootten; Patrick M Sexton
Journal:  Nature       Date:  2018-09-12       Impact factor: 49.962

View more
  14 in total

1.  Identification of Small-Molecule Positive Modulators of Calcitonin-like Receptor-Based Receptors.

Authors:  Erica R Hendrikse; Lydia P Liew; Rebekah L Bower; Muriel Bonnet; Muhammad A Jamaluddin; Nicole Prodan; Keith D Richards; Christopher S Walker; Garry Pairaudeau; David M Smith; Roxana-Maria Rujan; Risha Sudra; Christopher A Reynolds; Jason M Booe; Augen A Pioszak; Jack U Flanagan; Michael P Hay; Debbie L Hay
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-12

2.  Signaling profiles in HEK 293T cells co-expressing GLP-1 and GIP receptors.

Authors:  Yu-Zhe Wang; De-Hua Yang; Ming-Wei Wang
Journal:  Acta Pharmacol Sin       Date:  2021-08-26       Impact factor: 7.169

3.  The Nonpeptide Agonist MK-5046 Functions As an Allosteric Agonist for the Bombesin Receptor Subtype-3.

Authors:  Irene Ramos-Alvarez; Tatiana Iordanskaia; Samuel A Mantey; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2022-05-29       Impact factor: 4.402

4.  Rational development of a high-affinity secretin receptor antagonist.

Authors:  Maoqing Dong; Kaleeckal G Harikumar; Sweta R Raval; Juliana E Milburn; Carolyn Clark; Rafael Alcala-Torano; Juan C Mobarec; Christopher A Reynolds; Giovanna Ghirlanda; Arthur Christopoulos; Denise Wootten; Patrick M Sexton; Laurence J Miller
Journal:  Biochem Pharmacol       Date:  2020-03-23       Impact factor: 5.858

Review 5.  RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.

Authors:  Augen A Pioszak; Debbie L Hay
Journal:  Adv Pharmacol       Date:  2020-01-27

6.  Discovery of small molecule positive allosteric modulators of the secretin receptor.

Authors:  Daniela G Dengler; Kaleeckal G Harikumar; Sirkku Pollari; Qing Sun; Brock T Brown; Aki Shinoki-Iwaya; Robert Ardecky; Laurence J Miller; Eduard A Sergienko
Journal:  Biochem Pharmacol       Date:  2021-02-03       Impact factor: 5.858

7.  The metabolite GLP-1 (9-36) is neuroprotective and anti-inflammatory in cellular models of neurodegeneration.

Authors:  Yazhou Li; Elliot J Glotfelty; Tobias Karlsson; Lowella V Fortuno; Brandon K Harvey; Nigel H Greig
Journal:  J Neurochem       Date:  2021-10-21       Impact factor: 5.546

8.  Gs/Gq signaling switch in β cells defines incretin effectiveness in diabetes.

Authors:  Okechi S Oduori; Naoya Murao; Kenju Shimomura; Harumi Takahashi; Quan Zhang; Haiqiang Dou; Shihomi Sakai; Kohtaro Minami; Belen Chanclon; Claudia Guida; Lakshmi Kothegala; Johan Tolö; Yuko Maejima; Norihide Yokoi; Yasuhiro Minami; Takashi Miki; Patrik Rorsman; Susumu Seino
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 9.  Conformational Basis of G Protein-Coupled Receptor Signaling Versatility.

Authors:  Laura M Wingler; Robert J Lefkowitz
Journal:  Trends Cell Biol       Date:  2020-07-02       Impact factor: 20.808

10.  Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor.

Authors:  Zhaotong Cong; Li-Nan Chen; Honglei Ma; Qingtong Zhou; Xinyu Zou; Chenyu Ye; Antao Dai; Qing Liu; Wei Huang; Xianqiang Sun; Xi Wang; Peiyu Xu; Lihua Zhao; Tian Xia; Wenge Zhong; Dehua Yang; H Eric Xu; Yan Zhang; Ming-Wei Wang
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.